<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6835697/table_9" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 9</label>
  <p>Pharmaceutical formulations for the efficient delivery of GRFT.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Formulation Method</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Delivery Route</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Effects on Delivery</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">Ref.</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PLGA nanoparticles</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A biphasic release with an initial burst phase followed by a sustained release phase</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B60-marinedrugs-17-00567" ref-type="bibr">60</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Electrospun fibers</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maintenance of antiviral efficacy</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B57-marinedrugs-17-00567" ref-type="bibr">57</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FDI comprised of</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Good friability, hardness, and stability</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B58-marinedrugs-17-00567" ref-type="bibr">58</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mPEG-PLGA:PBA-co-PAA</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaginal</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High GRFT loading and pH-dependent release</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B59-marinedrugs-17-00567" ref-type="bibr">59</a>] 
   </td>
  </tr>
 </tbody>
</table>
